About
An International Dissolution Research Presentations Competition for the Early-stage Pharmaceutical Researchers
Follow Us
©Copyright 2023 SPDS India. All Rights Reserved.
Designed and maintained by Soni Digital
| Poster No. | Abstract title |
| P01 | A nano-emulsion based in situ gel of Moxifloxacin hydrochloride for ophthalmic delivery. |
| P02 | Comparative Evaluation of In Vitro Release and Permeation Profiles of Conventional and Advanced Delivery Systems for Herbal, Nutraceutical, and Cosmeceutical Agents |
| P03 | Development of an innovative albumin-based depot formulation for controlled release of Amphotericin B |
| P04 | Evaluation of critical material attributes on biorelevant dissolution method and PBBM-driven approach to establish IVIVR: A case study with Telmisartan |
| P05 | Improvement of Pharmaceutical Attributes of Ketoprofen using Natural Protein and Surfactants in Lyophilized Binary and Ternary Solid Dispersions and In Silico Molecular Modelling Studies |
| P06 | Lipid-Based Nanoformulations for Enhanced In Vitro Release and Permeation of Herbal, Nutraceutical, and Cosmeceutical Actives |
| P07 | Machine learning approach to assess the effect of menthol and limonene on drug permeation through skin |
| P08 | Nano meets micro: Improved cutaneous permeation and targeted delivery of hydrophobic phytoconstituent boswellic acid by amalgamating lipidic nanoparticle and dissolving microneedle for the management of rheumatoid arthritis |
| P09 | Nanostructured Lipid Carrier-Based Microneedle System for Controlled Transdermal Delivery in management of Alzheimer’s disease |
| P10 | Solubility enhancement of Acyclovir by co-crystallisation approach |
| P11 | Effect of polymer stabilized liquid-liquid phase separation on the permeability across corneal barrier |
| Sr | Abstract Title |
| M01 | Advanced Topical Formulation of Terbinafine Using Liquid Crystal Emulsion Technology: Enhanced Permeation and Controlled Release |
| M02 | Biorelevant Dissolution and Disintegration Assessment of a Transmucosal Orodispersible Film for Neuropsychiatric Management Using Modified USP Apparatus: A Comparative Study |
| M03 | Biorelevant Dissolution–Based PBBM for BCS Class IV Drug: Establishing IVIVR to Support BA/BE Studies |
| M04 | Boosting Solubility and Dissolution of Niclosamide Using Polymeric ASDs: Design, Development, and Evaluation |
| M05 | Cocrystallization and Precipitation Inhibitors: A Dual Strategy to Enhance the Dissolution Profile of Efonidipine Hydrochloride Ethanolate |
| M06 | Comparative Evaluation of Pullulan and Gelatin Recto-Vaginal Capsules Containing ph-Sensitive Nanoparticles Using USP Type IV Apparatus For Sustained Dual Drug Release |
| M07 | Comparative In Vitro Release Analysis of various Voriconazole-Loaded Topical Nanolipid Gels |
| M08 | Comparative In-vitro diffusion studies of Hydrocortisone and Hydrocortisone cream |
| M09 | Development & Evaluation of Topical Hydrogel of Mixed Polymeric Micelles for Delivery of Quercetin in Psoriasis treatment |
| M10 | Development and Evaluation of Chitosan-Based Celecoxib Nanosponges for Topical Anti-Inflammatory Effect |
| M11 | Development and Evaluation of Oral Films of Brexpiprazole with an Improved Solubility and Dissolution Profile |
| M12 | Development and Evaluation of Pediatric Anti-TB Sprinkle Formulation |
| M13 | Development and Validation of a Dissolution Method for Olanzapine Immediate-release Tablet Using HPLC |
| M14 | Development of a Voriconazole Dry Powder Inhaler for Targeted Pulmonary Delivery: In Vitro Release and Permeation Analysis |
| M15 | Dissolution based release of Graphene oxide loaded Hydrogel of Tofacitinib for management of Psoriasis. |
| M16 | Dissolution Driven Delivery of a novel ophthalmic nanofiber insert loaded with Dexamethasone sodium phosphate for the treatment of chronic posterior uveitis |
| M17 | Dissolution Enhancement of Itraconazole via CMEC-Based Solid Dispersions |
| M18 | Dissolution Study Approach For Development Of Caffeine Solid Dispersions For Taste Masking |
| M19 | Dissolution study guided Formulation and Evaluation of Taste Masked Orally Disintegrating Tablet of Levosulpiride for the Treatment of GERD. |
| M20 | Effect of Infill Variables on the Drug Release Rate of 3D-Printed Tablets |
| M21 | Enhancing Vaginal Health: In Vitro Permeation and Ex Vivo Release Studies of a Broad-Spectrum Antimicrobial Gel Formulated with Syzygium cumini Seed Extract. |
| M22 | Fabrication, In Vitro and In Vivo Optimization, and Characterization of Remdesivir - loaded floating Microspheres with using Methaacrylic Polymer Of Eudragit L 100 With 32 Factorial Design for the treatment of Covid19. |
| M23 | Formulation and Evaluation of Parsley Oil-Based Rutin Nanoemulsion and In-situ Thermosensitive Hydrogel for the treatment of Neurological Disorders |
| M24 | Formulation and In Vitro Release Evaluation of Celecoxib-Loaded Self-Microemulsifying Drug Delivery System |
| M25 | Formulation Development and In-vitro Studies of Modified Release Medicated Lozenges for Pediatric Population. |
| M26 | Green Approach to solubility enhancement of a poorly water soluble anti-gout drug using HME Technology |
| M27 | In Vitro Dissolution Enhancement of a BCS Class II Model Drug via Pelletized Oral Formulation Design |
| M28 | Microemulsion-based gel for skin delivery of tacrolimus and pramoxine hydrochloride |
| M29 | Multi-Unit Pellet Bilayer Tablet a Novel Regimen for the management of Hypertension |
| M30 | Nanoemulgel as a Topical Carrier for Hydrophobic NSAIDs: Comparative In Vitro Diffusion Studies |
| M31 | Release behavior of anticancer drug from Solid Lipid Nanoparticles |
| M32 | Rifampicin-loaded Mannose Conjugated-Nanostructured Lipid Carries (RMC-NLCs) Mucoadhesive Gel: A Novel Targeted Approach for Female Genital Tract Tuberculosis |
| M33 | Smart Microsponges: A Controlled Release Platform for Enhanced Topical Antifungal Delivery |
| M34 | Synthesis, Dissolution, and Cytotoxicity of Doxorubicin -Upconversion Nanoparticles for Breast Cancer Therapy |
| M35 | Systematic Approach Of Topical Herbal Anti-Inflammatory Drug Development Through In-Vitro Permeation Studies. |
| M36 | The Pivotal Influence of Dissolution Techniques on Controlled-Release Amorphous Solid Dispersion (CASD) Optimization |
| M37 | Thermosensitive In-situ Nasal Gels ff Rasagiline – Development and In Vitro release studies |
| M38 | Unveiling the Potential of Hydrophobic Ion-pair-loaded Self-Nanoemulsifying Drug Delivery System in Enhancing the Oral Bioavailability of Doxorubicin |
| M39 | Unveiling Tunable ‘Ghost’ To ‘Non-Ghost’ Matrix Transition and Drug Release Using DLP-3D Printing with Green Bio-Ionic Liquid (BIL) Resins |
An International Dissolution Research Presentations Competition for the Early-stage Pharmaceutical Researchers
©Copyright 2023 SPDS India. All Rights Reserved.
Designed and maintained by Soni Digital